Of Mice And Men And Cancer

Chemicals that promise to choke off the blood supply to tumors are now in human trials

A year after a frenzy of media hype seemed to promise--and then to rule out--a spectacular cancer cure, progress is quietly being made in the search for treatments that starve tumors by cutting off their blood supply. Some 20 compounds that halt the growth of new blood vessels, a process called angiogenesis, are now in human trials, and at this spring's cancer meetings, researchers are reporting promising results.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.